Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2019, Vol. 15 ›› Issue (01): 98 -102. doi: 10.3877/cma.j.issn.1673-5250.2019.01.017

Special Issue:

Review

Research progress of diagnosis and treatment on group B Streptococcus infection in perinatal period

Zhenzhen Wang1, Dan Lu2,(), Min Jiang2   

  1. 1. Dalian Medical University, Dalian 116044, Liaoning Province, China
    2. Medical College of Yangzhou University, Yangzhou 225009, Jiangsu Province, China
  • Received:2018-04-22 Revised:2018-12-17 Published:2019-02-01
  • Corresponding author: Dan Lu
  • About author:
    Corresponding author: Lu Dan, Email:
  • Supported by:
    Research Project of Maternal and Child Health of Jiangsu Provincial Commission of Health and Family Planning(F201663); General Program of Social Development of Science and Technology in Yangzhou City(YZ2017075)

Group B Streptococcus (GBS) is one of the important pathogens in adverse effects on pregnancy outcomes. GBS is also the leading cause of complications such as neonatal sepsis and meningitis and death of perinatal infants. There are ten different serotypes of GBS infection. GBS screening for pregnant women in perinatal period can provide references for clinicians taking intrapartum antibacterial prophylaxis (IAP) measures timely on pregnant women to prevent perinatal GBS infection, and effectively reduce infection rate of perinatal GBS. As a simple and safe method to prevent GBS infection, GBS vaccines have been paid more and more attention. GBS vaccines are currently the most prospective measure to prevent neonatal GBS infection through maternal immunity, but they have no preventive effects on neonatal-late onset GBS infection. This article focuses on adverse pregnancy outcomes, risk factors, effects of regional differences, diagnosis, treatment caused by perinatal GBS infection and current research development of GBS vaccines.

[1]
杨林东,杨露,孙丽洲.围生期新生儿不同血清型B族链球菌感染及其预防研究现状 [J/CD].中华妇幼临床医学杂志(电子版),2017,13(6): 621-626.
[2]
Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and Meta-analysis[J]. Lancet, 2012, 379(9815): 547-556.
[3]
Tevdorashvili G, Tevdorashvili D, Andghuladze M, et al. Prevention and treatment strategy in pregnant women with group B streptococcal infection[J]. Georgian Med News, 2015, 241(1): 15-23.
[4]
Simonsen KA, Anderson-Berry AL, Delair SF, et al. Early-onset neonatal sepsis[J]. Clin Microbiol Rev, 2014, 27(1): 21-47.
[5]
Melin P. Neonatal group B streptococcal disease: from pathogenesis to preventive strategies[J]. Clin Microbiol Infect, 2011, 17(9): 1294-1303.
[6]
Le Doare K, Heath PT. An overview of global GBS epidemiology[J]. Vaccine, 2013, 31(Suppl 4): D7- D12.
[7]
Adair CE, Kowalsky L, Quon H, et al. Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study[J]. CMAJ, 2003, 169(3): 198-203.
[8]
Dangor Z, Kwatra G, Izu A, et al. HIV-1 is associated with lower group B Streptococcus capsular and surface-protein IgG antibody levels and reduced transplacental antibody transfer in pregnant women[J]. J Infect Dis, 2015, 212(3): 453-462.
[9]
Pintye J, Saltzman B, Wolf E, et al. Risk factors for late-onset group B streptococcal disease before and after implementation of universal screening and intrapartum antibiotic prophylaxis[J]. J Pediatric Infect Dis Soc, 2016, 5(4): 431-438.
[10]
Libster R, Edwards KM, Levent F, et al. Long-term outcomes of group B streptococcal meningitis[J]. Pediatrics, 2012, 130(1): e8-e15.
[11]
Verani JR, McGee L, Schrag SJ, et al. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010[J]. MMWR Recomm Rep, 2010, 59(RR-10): 1-36.
[12]
Oddie S, Embleton ND. Risk factors for early onset neonatal group B streptococcal sepsis: case-control study[J]. BMJ, 2002, 325(7359): 308-310.
[13]
Nuccitelli A, Rinaudo CD, Maione D. Group B Streptococcus vaccine: state of the art[J]. Ther Adv Vaccines, 2015, 3(3): 76-90.
[14]
Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates[J]. N Engl J Med, 2002, 347(4): 233-239.
[15]
Szymusik I, Kosińska-Kaczyińska K, Pietrzak B, et al. Do we need a different approach to GBS screening?[J]. Ginekol Pol, 2014, 85(6): 456-460.
[16]
Kobayashi M, Vekemans J, Baker CJ, et al. Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries[J]. F1000Res, 2016, 5: 2355.
[17]
World Health Organization. WHO Recommendations for prevention and treatment of maternal peripartum infections[M]. Geneva: World Health Organization, 2015.
[18]
Ayieko P, Griffiths UK, Ndiritu M, et al. Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children[J]. PLoS One, 2013, 8(6): e67324.
[19]
Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease[J]. Obstet Gynecol, 2013, 121(3): 570-577.
[20]
Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implycations for a potential group B streptococcal vaccine[J]. Vaccine, 2013, 31(Suppl 4): D20-D26.
[21]
Heath PT. Status of vaccine research and development of vaccines for GBS [J]. Vaccine, 2016, 34(26): 2876-2879.
[22]
Chen VL, Avci FY, Kasper DL. A maternal vaccine against group B Streptococcus: past, present, and future[J]. Vaccine, 2013, 31(Suppl 4): D13-D19.
[23]
Dangor Z. Review on the association of group B Streptococcus capsular antibody and protection against invasive disease in infants[J]. Expert Rev Vaccines, 2015, 14(1): 135-149.
[1] Haoyuan Yang, Jie Gong, Qingwei Zou, Hang Ruan. Current research status on adverse pregnancy outcomes of maternal and infant in pregnant women with asthma[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 522-529.
[2] Tiantian Chen, Xiaodong Wang, Haiyan Yu. Pregnancy outcome of twin pregnancy with Gitelman syndrome: a case report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 559-568.
[3] Xiaoqing Ju, Yunjie Jin, Xiaoyan Wang. Influencing factors of uterine rupture during vaginal delivery in patients with scarred uterus after cesarean section[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 575-581.
[4] Juan Gu, Qingqing Sun, Fangfang Hu, Yijuan Cao, Yujuan Qi. Clinical application of endometrial receptivity array to improve pregnancy outcomes in women with repeated embryo implantation failure[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 582-587.
[5] Mengling Zhou, Zhiwei Xue, Shu Zhou. Changes in size of uterine myoma during pregnancy and its association with adverse pregnancy outcomes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 611-615.
[6] Li Chen, Xueqin Lei, Lian Duan, Yue Zeng, Guolin He. Analysis of influencing factors of success of trial of labor after twice cesarean sections and its pregnancy outcomes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 287-294.
[7] Ying Chen, Yanli Chen. Causes of heart rate variability and perinatal outcomes in elderly pregnant women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 295-301.
[8] Danyan Feng, Xiaohui Cao, Yuxia Shi. Effect of serum adiponectin and placental leucine aminopeptidase levels on pregnancy outcome in pregnant women with gestational diabetes mellitus[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 302-308.
[9] Guohua Ren, Xiaoxiao Du, Shanling Hong, Shuai Shao. Change and significance of serum interleukin-22, hydrogen sulfide, and osteoprotegerin levels of patients with hypertensive acute kidney injury in pregnancy[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(03): 150-155.
[10] Yuyan Zhang, Bin Hu, Weihong Zhang, Mei Xu, Hui Zhu, Xinyue Yang, Hailing Liu. Relationship between echocardiography parameters and liver function during the second trimester of pregnancy and their predictive value for adverse pregnancy outcomes[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 499-504.
[11] Xin Wang, Lin Liu, Zhejia Wen, Chunling Liu, Hong Zhang, Fang Lyu. Effect of stress exposure before pregnancy on subsequent pregnancy outcomes in mice[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(04): 431-437.
[12] Xiaoxiang Wu, Bo Yang, Jingxuan Li, Fengling Zhang, Guihui Guo, Shaopei Zheng. Predictive value of umbilical artery ultrasonography parameters, neutrophil to lymphocyte ratio, and sFlt-1/PLGF ratio for adverse pregnancy outcomes in patients with pregnancy induced hypertension syndrome[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(03): 266-271.
[13] Lizi Zhang, Dunjin Chen. Adverse outcomes and long­term prognosis of placenta accreta spectrum disorders[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 155-158.
[14] Xiaofang Zheng, Songquan Wei, Zhenxuan Huang, Wenshi Wu, Guimin Li, Hongxia Zhang, Qingping Jiang, Dunjin Chen, Lin Yu. Pregnancy outcome and pathological changes of the placenta in preeclampsia with fetal growth restriction[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(02): 85-92.
[15] Qunying Li, Liting Zheng, Yan Yu. Clinical analysis of 10 cases with a history of gynecological operation of uterine rupture in pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(02): 98-102.
Viewed
Full text


Abstract